Brussels approves ban on vaccines for United Kingdom | Community

Europe is facing a second epidemic of lack of progress in preventing its population due to low birth rates from the British company AstraZeneca. Dombrovsky reiterated that the Anglo-Swedish pharmaceutical company was “too far away” to comply with the terms, and pointed out that it would not even reach the 30 million doses it had recently confirmed for itself. For this reason, the invention of the 29 million dose – that is, doubling everything delivered in three months – was advanced to a warehouse at Cataland, a North American company in Anacni, 50 kilometers from Rome. Print, Provoked Brussels and many allies.

The awkwardness stems from the fact that those levels are not on the radar of the European Medicines Agency (EMA), which set all alarms. Downing Street immediately denied that those levels were imposed on England. Dombrovsky asked the company for an explanation of the vaccine. “It is the responsibility of the company to clarify its objectives,” he said. Institutional sources clarified this afternoon that those 29 million amounts correspond to several blocks: 16 million have been earmarked for EU countries (which were to be obtained between March and April) and 13 million are subject to the Kovacs initiative, the most vulnerable countries. A company spokesman said the vaccines had been manufactured outside the EU and taken to Italy. In addition, he denied that he had made any reservations, but was waiting for those vials to pass all quality controls.

Brussels insists no new mechanism has been developed to ban the export of vaccines to other countries. “This is not an export ban,” the commission’s deputy chairman insisted. However, Ursula will allow the EU to block exports, regardless of whether the companies comply with the agreements reached with Van der Lain’s executive. Henceforth, two new criteria will be added to grant export authorization: reciprocity (if the target country is sold to the EU) and proportionality (epidemiological and immunological status).

Although Dombrovsky confirmed that the new mechanism was not implemented in any particular country, he called for the analysis of data on exports to talk about “unity” or “responsibility”. “We have exported 10 million vaccines to the UK since the implementation of the accreditation system. The UK has not exported anything to the EU, ”he added. “Our mechanism is not aimed at any particular country, but we must ensure that our people in the EU are vaccinated. Now we are behind the schedule,” the vice president agreed.

Since the vaccine began to be approved for export, the EU has received a total of 381 export requests to 33 different locations. Only one person from Italy to Australia was detained. The rest got the green light. In total, it has been exported to 33 out of 43 countries. United Kingdom first recipient (10.9 million), Canada (6.6 million), Japan (5.4 million), Mexico (4.4 million), Saudi Arabia (1.5 million), Singapore (1.5 million), Chile (1.5 million), Hong Kong (1.3 million) ), South Korea (1 million) and Australia (one million).

Avoid possible leaks

For two criteria of reciprocity and proportionality, the EU adds another to the new regulation: a country avoiding deregulation through loopholes in the law. Prior to Wednesday’s reform, several neighboring countries, including Switzerland, Norway, Iceland, Israel, Serbia and Morocco, were exempt from the recognition. Henceforth, it is only for the most vulnerable countries, i.e. the beneficiaries of the Kovacs initiative. The EU, in this way, wants to be short to avoid exports to other countries, in fact, they are an intermediate station to another country, whether they sell to the EU or not.

Although Brussels insists the move was not made This A British government spokesman said after learning of the new regulation that the United Kingdom should seize exports: “We are all fighting the same pandemic: vaccines are an international measure; They are made in collaboration with the best scientists around the world. We will continue to work with our European partners to implement the vaccine. He added: “We are confident in our products, which must be delivered to everyone over the age of 50 by April 15 and by the end of July. Our plan to reopen the federation with caution through our road map has not changed either. “